[HTML][HTML] Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune …

…, T Kwaks, R Vogels, TJ Dalebout, SK Myeni… - npj Vaccines, 2020 - nature.com
Abstract Development of effective preventative interventions against SARS-CoV-2, the
etiologic agent of COVID-19 is urgently needed. The viral surface spike (S) protein of SARS-CoV-…

[HTML][HTML] SipB-SipC complex is essential for translocon formation

SK Myeni, L Wang, D Zhou - PLoS One, 2013 - journals.plos.org
The delivery of effector proteins by Salmonella across the host cell membrane requires a
subset of effectors secreted by the type III secretion system (TTSS) known as translocators. …

[HTML][HTML] The C terminus of SipC binds and bundles F-actin to promote Salmonella invasion

SK Myeni, D Zhou - Journal of Biological Chemistry, 2010 - ASBMB
Salmonella enterica serovar Typhimurium invade non-phagocytic cells by injecting bacterial
effector proteins to exploit the host actin cytoskeleton network. SipC is such a Salmonella …

[HTML][HTML] Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19

…, JJC de Vries, JJ Janse, M Roestenberg, SK Myeni… - Nature …, 2022 - nature.com
Systemic immune cell dynamics during coronavirus disease 2019 (COVID-19) are extensively
documented, but these are less well studied in the (upper) respiratory tract, where severe …

[HTML][HTML] Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

…, L Goksøyr, M Idorn, V Soroka, SK Myeni… - Nature …, 2021 - nature.com
The rapid development of a SARS-CoV-2 vaccine is a global priority. Here, we develop two
capsid-like particle (CLP)-based vaccines displaying the receptor-binding domain (RBD) of …

[HTML][HTML] A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection

…, N Mülling, DJ Brasem, MGM Camps, SK Myeni… - Nature …, 2022 - nature.com
Understanding the mechanisms and impact of booster vaccinations are essential in the
design and delivery of vaccination programs. Here we show that a three dose regimen of a …

[HTML][HTML] Immunogenicity and efficacy of one and two doses of Ad26. COV2. S COVID vaccine in adult and aged NHP

…, J Huizingh, K Kaszas, TJ Dalebout, SK Myeni… - Journal of Experimental …, 2021 - rupress.org
Safe and effective coronavirus disease–19 (COVID-19) vaccines are urgently needed to
control the ongoing pandemic. While single-dose vaccine regimens would provide multiple …

[HTML][HTML] Ad26. COV2. S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease

…, M van Heerden, TJ Dalebout, SK Myeni… - npj Vaccines, 2021 - nature.com
Previously we have shown that a single dose of recombinant adenovirus serotype 26 (Ad26)
vaccine expressing a prefusion stabilized SARS-CoV-2 spike antigen (Ad26.COV2.S) is …

[HTML][HTML] Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase

SK Myeni, PJ Bredenbeek, RCM Knaap… - Nature …, 2023 - nature.com
Coronaviruses express a papain-like protease (PLpro) that is required for replicase polyprotein
maturation and also serves as a deubiquitinating enzyme (DUB). In this study, using a …

Two-component nanoparticle vaccine displaying glycosylated spike S1 domain induces neutralizing antibody response against SARS-CoV-2 variants

…, A Suhrbier, TT Le, S Torres Morales, SK Myeni… - MBio, 2021 - Am Soc Microbiol
Vaccines pave the way out of the SARS-CoV-2 pandemic. Besides mRNA and adenoviral
vector vaccines, effective protein-based vaccines are needed for immunization against current …